UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026

Impact · against what's priced in

The reminder of the lead plaintiff deadline for the securities class action against Unicycive Therapeutics introduces a potential future liability for the company. While the underlying FDA failure is already reflected in the price, the formalization of legal claims creates a risk of future settlement costs or legal reserves.

UNCY−0.30

No priced-in read yet